CoreRx offers comprehensive drug product development services to the pharmaceutical and biotechnology industries. Supporting virtual, mid-size and multinational companies, CoreRx offers traditional, as well as customized formulation development and clinical material manufacturing solutions; solutions that maximize client investments, shorten development time and reduce overall costs. From 'first-in-man' drug development to full CMC support, CoreRx combines over 200 years of pharmaceutical development expertise to produce safe, effective and innovative drug products – on time and on budget.
CoreRx offers complete contract drug development support, from formulation feasibility studies for proof-of-principal to excipient compatibility evaluation, final product formulation optimization, cGMP clinical batch manufacture and complete analytical testing. Additionally, CoreRx has the facilities and expertise to work on the most challenging drug formulation issues, including solubility concerns, unstable compounds, innovative delivery options, low dose formulations and high potency compounds.
CoreRx offers comprehensive formulation development services for virtually every dosage form, catering to the needs of our clients and their specific drug delivery requirements.
CoreRx scientists have extensive expertise in drug formulation development, allowing innovative solutions and speed to market. Areas of expertise include:
CoreRx supports early and late stage development of solids (IR tablets, MR tablets and SR tablets), capsules, semi-solids (creams, gels, ointments, lotions), solutions, ophthalmics, parenterals and nasals. CoreRx has specific expertise in developing fixed dosage combination products, including bi-layer, tri-layer and multi-layer tablets, as well as multi-particulate delivery in capsule combination products. Additionally, CoreRx has extensive expertise in orally disintegrating tablets (ODT), taste masking and modified release delivery.
CoreRx offers diversified technical resources, capacity and flexibility to develop and manufacture virtually any clinical dosage form with strict quality compliance, speed and overall value.
CoreRx has innovative manufacturing capabilities for challenging products and the ability to customize manufacturing to client demands. Other services include:
At CoreRx our services center on small molecule analysis, including pre-formulation, method development, method qualification, method validation, drug substance testing, finished product release, and ICH stability storage and testing.
We can perform experimental design and execution for separation, isolation and analysis of pharmaceutical compounds, and HPLC, GC method development and validation for assay and related substances dissolution. We follow standard protocol for all development studies and can offer full document traceability. Other services include:
6101 Johns Road, Suite 8
United States of America
Tel: +1 813 514 9399